121 related articles for article (PubMed ID: 2658013)
1. Engraftment of T-depleted major histocompatibility complex-mismatched bone marrow in T-deficient versus natural killer-deficient recipients.
Schofer O; Buettner HJ; Kraemer M; Zepp F; Mannhardt W
Scand J Immunol; 1989 May; 29(5):627-9. PubMed ID: 2658013
[TBL] [Abstract][Full Text] [Related]
2. A radio-resistant perforin-expressing lymphoid population controls allogeneic T cell engraftment, activation, and onset of graft-versus-host disease in mice.
Davis JE; Harvey M; Gherardin NA; Koldej R; Huntington N; Neeson P; Trapani JA; Ritchie DS
Biol Blood Marrow Transplant; 2015 Feb; 21(2):242-9. PubMed ID: 25459639
[TBL] [Abstract][Full Text] [Related]
3. The role of host T cell subsets in bone marrow rejection directed to isolated major histocompatibility complex class I versus class II differences of bm1 and bm12 mutant mice.
Vallera DA; Taylor PA; Sprent J; Blazar BR
Transplantation; 1994 Jan; 57(2):249-56. PubMed ID: 7906058
[TBL] [Abstract][Full Text] [Related]
4. Absence of a facilitory role for NK 1.1-positive donor cells in engraftment across a major histocompatibility barrier in mice.
Blazar BR; Soderling CC; Koo GC; Vallera DA
Transplantation; 1988 May; 45(5):876-83. PubMed ID: 2897141
[TBL] [Abstract][Full Text] [Related]
5. Anti-NK cell treatment induces stable mixed chimerism in MHC-mismatched, T cell-depleted, nonmyeloablative bone marrow transplantation.
Cho SG; Shuto Y; Soda Y; Nakazaki Y; Izawa K; Uchimaru K; Takahashi S; Tani K; Tojo A; Asano S
Exp Hematol; 2004 Dec; 32(12):1246-54. PubMed ID: 15588949
[TBL] [Abstract][Full Text] [Related]
6. Donor CD8 cells prevent allogeneic marrow graft rejection in mice: potential implications for marrow transplantation in humans.
Martin PJ
J Exp Med; 1993 Aug; 178(2):703-12. PubMed ID: 8101864
[TBL] [Abstract][Full Text] [Related]
7. Enhancement of bone marrow allografts from nude mice into mismatched recipients by T cells void of graft-versus-host activity.
Lapidot T; Lubin I; Terenzi A; Faktorowich Y; Erlich P; Reisner Y
Proc Natl Acad Sci U S A; 1990 Jun; 87(12):4595-9. PubMed ID: 2191295
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of natural killer cell-mediated bone marrow graft rejection by allogeneic major histocompatibility complex class I, but not class II molecules.
Ohlén C; Höglund P; Sentman CL; Carbone E; Ljunggren HG; Koller B; Kärre K
Eur J Immunol; 1995 May; 25(5):1286-91. PubMed ID: 7774631
[TBL] [Abstract][Full Text] [Related]
9. In vivo administration of anti-CD3 monoclonal antibodies or immunotoxins in murine recipients of allogeneic T cell-depleted marrow for the promotion of engraftment.
Blazar BR; Hirsch R; Gress RE; Carroll SF; Vallera DA
J Immunol; 1991 Sep; 147(5):1492-503. PubMed ID: 1831826
[TBL] [Abstract][Full Text] [Related]
10. Acute rejection of murine bone marrow allografts by natural killer cells and T cells. Differences in kinetics and target antigens recognized.
Murphy WJ; Kumar V; Bennett M
J Exp Med; 1987 Nov; 166(5):1499-509. PubMed ID: 3316472
[TBL] [Abstract][Full Text] [Related]
11. Blockade of the CD40/CD154 pathway enhances T-cell-depleted allogeneic bone marrow engraftment under nonmyeloablative and irradiation-free conditioning therapy.
Pan Y; Luo B; Sozen H; Kalscheuer H; Blazar BR; Sutherland DE; Hering BJ; Guo Z
Transplantation; 2003 Jul; 76(1):216-24. PubMed ID: 12865813
[TBL] [Abstract][Full Text] [Related]
12. Donor T cell and host NK depletion improve the therapeutic efficacy of allogeneic bone marrow cell reconstitution in the nonmyeloablatively conditioned tumor-bearing host.
Hummel S; Wilms D; Vitacolonna M; Zöller M
J Leukoc Biol; 2002 Nov; 72(5):898-912. PubMed ID: 12429711
[TBL] [Abstract][Full Text] [Related]
13. An absence of T cells in murine bone marrow allografts leads to an increased susceptibility to rejection by natural killer cells and T cells.
Murphy WJ; Kumar V; Cope JC; Bennett M
J Immunol; 1990 May; 144(9):3305-11. PubMed ID: 2329274
[TBL] [Abstract][Full Text] [Related]
14. A correlation between conditioning and engraftment in recipients of MHC-mismatched T cell-depleted murine bone marrow transplants.
Soderling CC; Song CW; Blazar BR; Vallera DA
J Immunol; 1985 Aug; 135(2):941-6. PubMed ID: 3891856
[TBL] [Abstract][Full Text] [Related]
15. Effect of selective T cell depletion of host and/or donor bone marrow on lymphopoietic repopulation, tolerance, and graft-vs-host disease in mixed allogeneic chimeras (B10 + B10.D2----B10).
Ildstad ST; Wren SM; Bluestone JA; Barbieri SA; Stephany D; Sachs DH
J Immunol; 1986 Jan; 136(1):28-33. PubMed ID: 2933464
[TBL] [Abstract][Full Text] [Related]
16. Multilineage engraftment with minimal graft-versus-host disease following in utero transplantation of S-59 psoralen/ultraviolet a light-treated, sensitized T cells and adult T cell-depleted bone marrow in fetal mice.
Bhattacharyya S; Chawla A; Smith K; Zhou Y; Talib S; Wardwell B; Cowan MJ
J Immunol; 2002 Dec; 169(11):6133-40. PubMed ID: 12444116
[TBL] [Abstract][Full Text] [Related]
17. Long-term mixed chimerism after immunologic conditioning and MHC-mismatched stem-cell transplantation is dependent on NK-cell tolerance.
Westerhuis G; Maas WG; Willemze R; Toes RE; Fibbe WE
Blood; 2005 Sep; 106(6):2215-20. PubMed ID: 15928035
[TBL] [Abstract][Full Text] [Related]
18. A second prophylactic MHC-mismatched bone marrow transplantation protects against rat acute myeloid leukemia (BNML) without lethal graft-versus-host disease.
Nestvold JM; Omdal BK; Dai KZ; Martens A; Benestad HB; Vaage JT; Rolstad B
Transplantation; 2008 Jan; 85(1):102-11. PubMed ID: 18192919
[TBL] [Abstract][Full Text] [Related]
19. Donor T cells lacking Fas ligand and perforin retain the capacity to induce severe GvHD in minor histocompatibility antigen mismatched bone-marrow transplantation recipients.
Marks L; Altman NH; Podack ER; Levy RB
Transplantation; 2004 Mar; 77(6):804-12. PubMed ID: 15077018
[TBL] [Abstract][Full Text] [Related]
20. Role of classical (RT1.A) and nonclassical (RT1.C) MHC class I regions in natural killer cell-mediated bone marrow allograft rejection in rats.
Engh E; Benestad HB; Strøm-Gundersen I; Vaage JT; Bell EB; Rolstad B
Transplantation; 1998 Feb; 65(3):319-24. PubMed ID: 9484746
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
